Close Menu

Precision Oncology Research Funding

News on research grants, RFPs, government funding trends in genetics, genomics, and molecular diagnostics.

Researchers will use the grant to develop a drug testing platform using patient-derived tumor organoids to predict treatment outcomes for patients.

BioMark Diagnostics has been collaborating on the test with the Metabolomics Innovation Centre at the University of Alberta since early 2015.

With a new $16 million NCI grant, Count Me In is working with the Broad and Dana-Farber to engage osteosarcoma and leiomyosarcoma patients in their own care and in research.

The grant will fund an investigation into long noncoding RNA and the role it plays in differing prognoses between Black and white breast cancer patients.